1.. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44(4):642-50.
4.. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290(3):F625-31.
6.. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010;12(6):223.
7.. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46.
9.. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131(5):363-75.
10.. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49(1):31-62.
11.. Nygård O, Vollset SE, Refsum H, Brattström L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999;246(5):425-54.
13.. Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, et al. Role of blood pressure, uric acid, and hemorheo-logical parameters on plasma homocyst(e)ine concentration. Atherosclerosis 1995;114(2):175-83.
14.. Tsutsumi Z, Moriwaki Y, Yamamoto T, Takahashi S, Hada T, Fukuchi M. Total plasma homocysteine is not increased in Japanese patients with gout. J Rheumatol 2002;29(8):1805-6.
16.. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004;63(1):49-63.
19.. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis 1972;25(6):329-43.
20.. National Institute on Alcohol Abuse and Alcoholism. Alcohol screening and brief intervention for youth: A practitioner's guide. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2011. [Accessed February 28, 2015].. http://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/YouthGuide.pdf.
21.. Yokoyama A, Muramatsu T, Ohmori T, Kumagai Y, Higuchi S, Ishii H. Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6(12):1105-7.
25.. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24(8):1403-10.
26.. Papezikova I, Pekarova M, Lojek A, Kubala L. The effect of uric acid on homocysteine-induced endothelial dysfunction in bovine aortic endothelial cells. Neuro Endocrinol Lett 2009;30(Suppl 1):112-5.
28.. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000;148(1):131-9.
29.. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283(18):2404-10.
30.. Barak AJ, Beckenhauer HC, Tuma DJ. Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol 2002;26(2):65-7.
31.. Brecher AS, Lehti MD. A hypothesis linking hypoglycemia, hyperuricemia, lactic acidemia, and reduced gluconeogenesis in al-coholics to inactivation of glucose-6-phosphatase activity by acetaldehyde. Alcohol 1996;13(6):553-7.